Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8V76

Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with compound 15

Summary for 8V76
Entry DOI10.2210/pdb8v76/pdb
DescriptorInositol polyphosphate multikinase, N-{(3P)-3-[(5P)-5-(2H-tetrazol-5-yl)-2,1-benzoxazol-3-yl]phenyl}cyclopentanecarboxamide, SULFATE ION, ... (4 entities in total)
Functional Keywordsstructure-based inhibitor development, kinase, inhibitor, inositol polyphosphate, inositol polyphosphate kinase, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
More
Total number of polymer chains1
Total formula weight30298.37
Authors
Wang, H.,Shears, S.B. (deposition date: 2023-12-04, release date: 2024-12-11, Last modification date: 2025-12-10)
Primary citationWang, H.,Shears, S.B.,Blind, R.D.
Structural Rationalization of IPMK Inhibitor Potency.
J.Med.Chem., 68:24316-24325, 2025
Cited by
PubMed Abstract: Inositol polyphosphate multikinase (IPMK) is a kinase linked to several cancers; recent development of a large panel of ATP-competitive inhibitors has reinvigorated enthusiasm for targeting IPMK. However, the structural basis for how these inhibitors achieve high potency is unknown. Herein, we report 14 novel cocrystal structures (1.7-2.0 resolution) of human IPMK kinase domain with these inhibitors. We also apply a radiolabeled assay and isothermal titration calorimetry that permit high-confidence IC and value determinations. The structures reveal a pocket in the ATP-binding site engaged by the most potent inhibitors. Two ordered waters also participate in hydrogen-bonding networks associated with the most potent inhibitors. In addition to providing the molecular basis for observed increases in potency and selectivity, the data presented here provide a toolbelt of 14 novel inhibitor-bound structures of human IPMK that can serve as a reference for all future IPMK structure-based inhibitor development efforts.
PubMed: 41237254
DOI: 10.1021/acs.jmedchem.5c02314
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon